Adalimumab
adalimumab-adaz
- Strength
- 20 mg/.2mL
- Form
- Injection, Solution
- Class
- Tumor Necrosis Factor Blocker
Sandoz Inc
Not stocked by us — reference only
AMJEVITA
adalimumab-atto
Listed by Amgen, Inc
- Strength
- 40 mg/.4mL
- Form
- Injection
- Route
- Subcutaneous
- Class
- Tumor Necrosis Factor Blocker
What it contains
- Adalimumab 40 mg/.4mL
FDA record
| Dosage form | Injection |
|---|---|
| Route | Subcutaneous |
| Drug class | Tumor Necrosis Factor Blocker |
| Approval route | BLA — biologic licence |
| NDC code | 55513-479 |
| FDA application | BLA761024 |
| RxNorm concept | 2627711 |
| Package sizes listed | 2 |
| Marketed since | August 2023 |
Other products containing Adalimumab
See allSame active ingredient, different manufacturer, strength or form. Products matching on both ingredient and strength are usually interchangeable — but confirm before switching, especially with modified-release forms.
Adalimumab
adalimumab-adaz
- Strength
- 10 mg/.1mL
- Form
- Injection, Solution
- Class
- Tumor Necrosis Factor Blocker
Sandoz Inc
Not stocked by us — reference only
Adalimumab
adalimumab-adaz
- Strength
- 80 mg/.8mL
- Form
- Injection, Solution
- Class
- Tumor Necrosis Factor Blocker
Sandoz Inc
Not stocked by us — reference only
Adalimumab
adalimumab-adaz
- Strength
- 40 mg/.4mL
- Form
- Injection, Solution
- Class
- Tumor Necrosis Factor Blocker
Sandoz Inc
Not stocked by us — reference only
Adalimumab-bwwd
- Strength
- 40 mg/.4mL
- Form
- Solution
- Class
- Tumor Necrosis Factor Blocker
Cordavis Limited
Not stocked by us — reference only
Adalimumab-bwwd
- Strength
- 40 mg/.4mL
- Form
- Solution
- Class
- Tumor Necrosis Factor Blocker
Cordavis Limited
Not stocked by us — reference only
AMJEVITA
adalimumab-atto
- Strength
- 80 mg/.8mL
- Form
- Injection
- Class
- Tumor Necrosis Factor Blocker
Amgen USA Inc.
Not stocked by us — reference only
AMJEVITA
adalimumab-atto
- Strength
- 40 mg/.4mL
- Form
- Injection
- Class
- Tumor Necrosis Factor Blocker
Amgen USA Inc.
Not stocked by us — reference only
Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.